ClinicalTrials.Veeva

Menu

Mucin Levels in Dry Eye and Normal Populations

Ora, Inc. logo

Ora, Inc.

Status

Completed

Conditions

Dry Eye

Study type

Observational

Funder types

Industry

Identifiers

NCT05911555
13-270-0004

Details and patient eligibility

About

The purpose of this study is to evaluate changes in ocular mucin levels in response to a drying environment in subjects with dry eye disease as well as patients who report no history of dry eye disease.

It is expected that exposure to the dry environment will alter mucin levels in different ways when comparing the two groups.

Full description

This is a single-center, two visit, pilot, drying environment study (CAE). There will be two different groups of subjects enrolled into this study: dry eye subjects and subjects with no prior diagnosis of dry eye.

All subjects will undergo safety and dry eye assessments as well as tear collection prior to and after being exposed to a dry environment. They will also return the following day to undergo dry eye assessments, tear collection, and safety procedures again.

Enrollment

34 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Be male or female of any race, at least 18 years of age at Visit 1.
  • Have provided verbal and written informed consent.
  • Have a best corrected visual acuity of +0.70 logMAR or better in both eyes at Visit 1, as assessed by Early Treatment of Diabetic Retinopathy Study (ETDRS) chart.
  • If a woman of childbearing potential, have a negative urine pregnancy test at Visit 1 and agree to use a medically acceptable form of birth control throughout the study duration . [Females are considered of childbearing potential unless they are surgically sterilized (bilateral tubal ligation, hysterectomy or bilateral oophorectomy) or post-menopausal (at least 12 months since last menses).]
  • Have previously completed a recent trial OR not completed a recent trial AND report no symptoms of dry eye disease.

Exclusion criteria

  • Have planned surgery during trial period
  • Female currently pregnant, planning a pregnancy or lactating
  • Use of disallowed medications
  • Have ocular infections, or ocular conditions that could affect study parameters
  • Have used an investigational drug or device within 30 days of start of study
  • Female that is currently pregnant, planning a pregnancy or lactating

Trial design

34 participants in 2 patient groups

Non-Dry Eye Subjects
Description:
Subjects with no reported history of dry eye disease will be enrolled
Dry Eye Disease
Description:
Subjects who have been diagnosed with dry eye disease in a previous trial will be enrolled.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems